Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA)

10 filings reported holding PCSA - Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 98.9K shares of 55.6M outstanding shares and own 0.18% of the company stock.
Largest 10 shareholders include HRT FINANCIAL LP (32K shares), VANGUARD GROUP INC (24.4K shares), GEODE CAPITAL MANAGEMENT, LLC (22K shares), Miracle Mile Advisors, LLC (10K shares), UBS Group AG (7.91K shares), Tower Research Capital LLC (TRC) (2.46K shares), WELLS FARGO & COMPANY/MN (154 shares), BANK OF AMERICA CORP /DE/ (25 shares), MACROVIEW INVESTMENT MANAGEMENT LLC (0 shares), and Allworth Financial LP (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.